Guangdong Marubi Biotechnology Co Ltd
SSE:603983
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
20.56
32.23
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Guangdong Marubi Biotechnology Co Ltd
Operating Income
Guangdong Marubi Biotechnology Co Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
G
|
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
|
Operating Income
ÂĄ281.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Hengan International Group Company Ltd
HKEX:1044
|
Operating Income
ÂĄ4.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
||
Proya Cosmetics Co Ltd
SSE:603605
|
Operating Income
ÂĄ1.7B
|
CAGR 3-Years
41%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
||
Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
|
Operating Income
ÂĄ807.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
||
By-health Co Ltd
SZSE:300146
|
Operating Income
ÂĄ2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
||
G
|
Giant Biogene Holding Co Ltd
HKEX:2367
|
Operating Income
ÂĄ1.7B
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Guangdong Marubi Biotechnology Co Ltd
Glance View
Guangdong Marubi Biotechnology Co., Ltd. engages in the research, development, design, production, sales and services of cosmetics. The company is headquartered in Guangzhou, Guangdong and currently employs 1,197 full-time employees. The company went IPO on 2019-07-25. The firm's products mainly include eye care products, skin cleansing products, skin care products (cream lotion and mask), make-up products and others. The firm's brands mainly include Maru, Cac and Passional Lover. The firm mainly conducts its businesses in domestic market.
See Also
What is Guangdong Marubi Biotechnology Co Ltd's Operating Income?
Operating Income
281.5m
CNY
Based on the financial report for Sep 30, 2024, Guangdong Marubi Biotechnology Co Ltd's Operating Income amounts to 281.5m CNY.
What is Guangdong Marubi Biotechnology Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-13%
Over the last year, the Operating Income growth was 33%. The average annual Operating Income growth rates for Guangdong Marubi Biotechnology Co Ltd have been 2% over the past three years , -13% over the past five years .